MKI67 and neoplasm: Numbers of Ki67 positive tumour cells reduced by 85% in mice receiving anakinra via the treatment protocol and 73% in mice administered the preventative protocol, compared with placebo (P > 0.01 for treatment and preventative compared with placebo).